Jason Ehrlich
Nessuna posizione attualmente
Patrimonio netto: 372 163 $ in data 29/02/2024
Profilo
Jason S. Ehrlich occupa la posizione di Chief Medical & Development Officer presso Kodiak Sciences, Inc. Nella sua carriera passata il Dr. Ehrlich ha occupato la posizione di Global Head-Clinical Ophthalmology presso Genentech, Inc. Si è laureato alla Princeton University e ha conseguito un dottorato alla Stanford University School of Medicine.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
KODIAK SCIENCES, INC.
0.12% | 24/06/2023 | 61 924 ( 0.12% ) | 372 163 $ | 29/02/2024 |
Precedenti posizioni note di Jason Ehrlich
Società | Posizione | Fine |
---|---|---|
KODIAK SCIENCES INC. | Chief Tech/Sci/R&D Officer | 25/08/2023 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2018 |
Formazione di Jason Ehrlich
Princeton University | Undergraduate Degree |
Stanford University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Kodiak Sciences, Inc. |